The Global Health Body Raises Concern Over Acute Shortage of Weight-Loss Injections

Fewer than one in 10 individuals eligible to benefit from obesity jabs like Wegovy have access to them, warns the World Health Organization as it publishes its initial guidance on the medications.

Considering more than one billion people worldwide currently classified as obese, it is advocating for broader and more equitable availability to these injectable treatments.

Based on estimates, in excess of 2,000,000,000 will be obese by 2030 without intervention.

"The latest guidelines acknowledges that excess weight is a long-term condition that can be addressed with holistic and continuous care," stated WHO director-general Tedros Adhanom Ghebreyesus.

Significant expense, limited production capacity, and supply-chain constraints are key barriers to universal availability to the injections that can help people shift significant body mass, notes the body.

Skinny Jab Supply Crisis

Even under the present best projected case, the manufacturing of these medications might only reach about 100 million people – less than 10% of the global need, as stated by the health organization.

The guideline encourages countries and companies to widen availability, by measures including licensing agreements.

A patent on a key compound – the main component of the drug Wegovy – is scheduled to end in multiple nations in 2026.

How Obesity Injections Work

GLP-1 drugs replicate a biological compound to reduce digestion speed, reduce hunger and enhance satiety so users eat less.

People typically begin shedding pounds after several weeks of beginning the once-weekly jabs.

Research indicates people may put most of the weight back on after a year of halting the drug, because their typical hunger resume.

Being overweight or obese elevates your risk for experiencing medical conditions, like diabetes, heart disease, brain attack, and some malignancies.

Obesity concerns individuals in all nations and was responsible for over three and a half million deaths worldwide in 2024, as per the health agency.